Why trade secrets matter: Covid vaccine manufacturing scale-up and the WTO’s proposed IP waiver

Geneva Network is organising a discussion on the role of trade secrets in Covid-19 vaccine manufacturing. A panel of global experts, including Innovation Council’s own Mark Schultz, will shed light on how this important intellectual property right works, how it relates to vaccine manufacturing, and the implications of the IP waiver currently under discussion at the WTO.

The webinar will take place on September 14, 2021: 13.00 – 14.00 GMT.

Read the full story and register here.